Octreotide treatment of acromegaly during pregnancy.
Mikhail
Nasser
N
D000172:Acromegaly / Q000188:drug therapy* / Q000209:etiology; D000328:Adult; D016903:Drug Monitoring; D005260:Female; D013006:Growth Hormone / Q000097:blood; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D008279:Magnetic Resonance Imaging; D015282:Octreotide / Q000627:therapeutic use*; D010911:Pituitary Neoplasms / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000601:surgery; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000209:etiology; D011256:Pregnancy Outcome; D012449:Safety; D016896:Treatment Outcome
D006728:Hormones; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone; D015282:Octreotide